Literature DB >> 8765038

Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells.

E Michaëlsson1, J Broddefalk, A Engström, J Kihlberg, R Holmdahl.   

Abstract

It is well known that T cells recognize antigen as processed peptides bound to major histocompatibility complex molecules on the surface of antigen-presenting cells. Recently, it has been shown that T cells can specifically recognize synthetic glycopeptides. However, whether glycopeptides are selected for presentation during antigen processing of glycoproteins and eventually elicit carbohydrate-specific T cells is still an open question. In this study, we utilized synthetic glycopeptides to analyze T cell recognition of the naturally glycosylated immunodominant peptide representing type II collagen (CII) residues 256-270. In this peptide, lysines at positions 264 and 270 may be post-translationally modified by hydroxylation and subsequent O-linked glycosylation with beta-galactosyl or alpha-glucosyl-(1-->2)-beta-galactosyl residues. T cell hybridomas established from type II collagen-immunized mice specifically recognized CII 256-270 with either galactose or glucosyl-galactose at position 264. The T cell hybridoma recognizing glucosyl-galactose displayed no cross-reactivity either to galactose or to the structurally different alpha-galactosyl-(1-->4)-beta-galactose. Furthermore, the T cell hybridoma recognizing galactose did not cross-react to glucosyl-galactose or galactosyl-galactose, indicating that the antigen-presenting cells (bulk spleen cells, lipopolysaccharide-stimulated spleen cells, anti-CD40-stimulated spleen cells, peritoneal exudate cells or CFA-primed lymph node cells) inefficiently processed carbohydrates when the antigen was given as a glycopeptide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765038     DOI: 10.1002/eji.1830260835

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Colchicum autumnale from Het Cruydtboeck by Rembertus Dodonaeus.

Authors:  A Boonen; L van de Putte
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis.

Authors:  S Drinda; S Franke; C C Canet; P Petrow; R Bräuer; C Hüttich; G Stein; G Hein
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Dietary modifications: food dependent autoimmunity in coeliac disease.

Authors:  A M Mowat
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

4.  Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma.

Authors:  Stacy A Malaker; Michael J Ferracane; Florence R Depontieu; Angela L Zarling; Jeffrey Shabanowitz; Dina L Bai; Suzanne L Topalian; Victor H Engelhard; Donald F Hunt
Journal:  J Proteome Res       Date:  2016-09-13       Impact factor: 4.466

Review 5.  Nitroxidized-Albumin Advanced Glycation End Product and Rheumatoid Arthritis.

Authors:  Akhlas Tarannum; Zarina Arif; Khursheed Alam; Shafeeque Ahmad; Moin Uddin
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

6.  Immunogenicity of bacterial carbohydrates: cholera toxin modulates the immune response against dextran B512.

Authors:  E Sverremark; C Fernandez
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

7.  T cell surface redox levels determine T cell reactivity and arthritis susceptibility.

Authors:  Kyra A Gelderman; Malin Hultqvist; Jens Holmberg; Peter Olofsson; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

Review 8.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

9.  Characterization of T cell hybridomas raised against a glycopeptide containing the tumor-associated T antigen, (betaGal (1-3) alphaGalNAc-O/Ser).

Authors:  Monika Gad; Ole Werdelin; Morten Meldal; Shiro Komba; Teis Jensen
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

10.  Critical role of glycosylation in determining the length and structure of T cell epitopes.

Authors:  Tamás G Szabó; Robin Palotai; Péter Antal; Itay Tokatly; László Tóthfalusi; Ole Lund; György Nagy; András Falus; Edit I Buzás
Journal:  Immunome Res       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.